InvestorsHub Logo
Followers 8
Posts 860
Boards Moderated 0
Alias Born 12/09/2017

Re: biopharm post# 321051

Tuesday, 12/19/2017 2:44:36 PM

Tuesday, December 19, 2017 2:44:36 PM

Post# of 345969
WHO CARES, THE COMP IS A CDMO NOW
ANY REFERENCE TO TRIALS IS IRRELEVANT


Phase II exceeded the placbo by 109% MOS improvement and Peregrine filed for phase III based upon 60% MOS conservative improvement of MOS

So you see....where does it say they set up phase III to equal performance of placebo ? Lol sounds like some non truths in your opinion

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News